The reactivities of N-iodosuccinimide and iodine with various goitrogenic compounds were studied with dimethylsulfoxide through which nitrogen had been bubbled as a solvent. Although iodine does not react with all of the compounds, N-iodosuccinimide does react with all of them. N-Iodosuccinimide may, therefore, serve as an interesting model for the "active iodine" of the thyroid.
The thyroid gland synthesizes the thyroid hormones, thyroxine and triiodothyronine. Inorganic iodide is oxidized by iodide peroxidase to an unknown "active iodine" species that iodinates certain tyrosines of the thyroglobulin molecule to mono-and diiodotyrosine residues. Some of these proteinbound iodinated tyrosines are coupled by the same peroxidase to yield thyroglobulin-bound thyroxine and triiodothyronine.
The goitrogens are compounds that prevent the biosynthesis of the thyroid hormones by inhibiting the iodination and/ or the coupling reactions (1). Several chemical classes of compounds are now known to have goitrogenic activity. They include: thionamides (2, 3), sulfonamides (2, 3), metahydroxyphenols (4), hydrazines (5) , and the compounds 3-amino-1, 2,4-triazole (6) and 1,1,3-tricyano-2-amino-1-propene (7) .
Little systematic chemical work has been done on the reactivities of the goitrogens with different types of iodinating agents. N-Iodosuccinimide, a "positive iodine" reagent, is similar to 12 in its ability to iodinate the phenol ring, but it has a higher oxidation potential (8) . It was therefore of interest to compare the reactivities of I2 and N-iodosuccinimide with the goitrogens. Under the conditions described herein, Niodosuccinimide was found to react with all the classes of goitrogens tested, while 12 reacts only with some classes. These results suggest that N-iodosuccinimide is a better model for the "active iodine" than is I2.
Preliminary spectrophotometric studies showed that the yellow color of solutions resulting from the reaction of a compound with N-iodosuccinimide in (CH3)2SO through which N2 had been bubbled was due to the presence of 12 only (420-nm peak) and/or the presence of I3-(366-nm peak). 12 is presumed to result from the reduction of N-iodosuccinimide to I -by the drug in a multistep reaction (the goitrogen is oxidized simultaneously), and the reaction of this I-with excess N-iodosuccinimide to give 12 and/or 3-. Spectrophotometric Measurements were performed on a recording Beckman DM spectrophotometer in a range between 600 and 340 nm. Water from a water bath maintained at 250 was circulated through the cuvette chamber.
Reactivity of N-lodosuccinimide. Since a slow spontaneous yellowing of N-iodosuccinimide solutions occurs, it was necessary to use a blank containing the identical N-iodosuccinimide solution that is used in the reaction for most measurements. Fresh, almost colorless N-iodosuccinimide solutions were used. Usually the concentration of N-iodosuccinimide in the cuvette was 10 jsrol in 2 ml (5 mM). However, a series of experiments was run with 0.1-100 Amol of N-iodosuccinimide in 2 ml.
Every compound was checked at least at four different concentrations (from 0.01 to 2 ,umol/2 ml) with 10 ,umol of Niodosuccinimide.
In a routine determination, an aliquot of 0.01-0.1 ml of a (CH3)2SO solution of the compound (usually 10 mM) was added to 2 ml of a (CH3)2SO solution of N-iodosuccirimide in the cuvette, mixed by bubbling with N2, and scanned immediately from 600 to 340 nm. The scan speed was 40 nm/ min. Therefore, the yield of 12, obtained from A420 nm was the result of 5 min of reaction time that included the 30-sec time period for mixing and the N2 bubbling of the cuvette. The reaction for most, but not all, of the compounds was almost finished by this time. (9, 10) . Since the commercially available "Certified Grade" is used throughout this study, the spectrum of 2.000- All samples were in a final volume of 2 ml. (Fig. 1) ; Group 2 contains compounds that produce a maximum at 366 nm (I-) or peaks of unknown complexes that absorb in that region (Fig. 2) ; and Group 3 contains compounds that do not react with N-iodosuccinimide to a significant degree and/or produce small individual absorption peaks differing from those of Groups 1 and 2 (Fig. 3) .
In Table 1 are listed the calculated yields of 12 resulting from the reaction of 10 Mmol of N-iodosuccinimide and 1 ,umol of compound. In the simple and quantitative oxidation of a thiol to its disulfide by N-iodosuccinimide, 1 mol of thiol would yield 0.5 mol of disulfide, and 0.5 mol of I-would be eliminated. This I-, in the presence of excess N-iodosuccinimide, would yield 0.5 mol of I2.
3-Mercapto-1,2,4-triazole approximates this theoretical value most closely (0.55). The three thiouracil derivatives tested give yields between 0.58 and 0.76 s&mol of 12 per umol of compound. These indicate an oxidation of the disulfide to a higher oxidation state. 1 /hmol of the disodium salt of uracil disulfide (13) produced a peak at 366 nm, equivalent to 0.17 Mmol of I2 when reacted with N-iodosuccinimide in the usual manner. 1,1,3-Tricyano-2-amino-1-propene and 3-amino-1,2,4-triazole each yields about 1 mol of I2 per mol, suggesting-that one equivalent of I -was eliminated during the reaction. Isonicotinic acid hydrazide, which has two nitrogens in the side chain, yielded 1.5 mol of I2 per mol. 4,4'-Methylene dianiline (containing two anilino groupings) produced two peaks. The 420-nm peak was equivalent to 1.75 mol of 12 Group 2 consists of four compounds, if one considers the second peak of 4,4'-methylene dianiline. 4-Aminobenzoic acid reacts strongly to yield an I3-spectral peak equivalent to about 1 mol of I2 per mol. Sulfadiazine and sulfanilamide yield spectral peaks at 352 and 354 nm, respectively, shifting with concentration of reactants. Since no knowledge is available concerning the nature of these peaks, calculations of the 3-eliminated cannot be made. This latter statement applies, also, to the second peak of 4,4'-methylenedianiline.
Group 3 presents the data for some nongoitrogenic compounds. The problem of the nature of the spectral peaks that do not occur at 420 or 366 nm presents itself again; however, if one accepts the absorbance found for each compound at face value, one may see that N-acetylsulfadiazine and Nacetylsulfanilamide react about one order of magnitude less than their goitrogenic parent substances, sulfadiazine and sulfanilamide. Resorcinol dimethylester (Group 3) yields 13-equivalent to 0.02 mol of I2 per mol, while resorcinol in Group 1 gives 0.31 mol of I2 per mol. Urea, uracil, barbital, diethylhydantoin, and imidazole do not react with N-iodosuccinimide, but their goitrogenic thioanalogs do. Resorcinol and 4-aminosalicylic acid react, but phenol and salicylic acid do not.
The reactivity of a compound with I2 is measured under conditions that are different from those for N-iodosuccinimide. Although the reactivity with N-iodosuccinimide is determined in the presence of an excess of N-iodosuccinimide, the reaction with I2 is done in the presence of an excess of test compound. The capacity of a compound to be oxidized by I2 (i.e., I2 reduction) is determined under conditions that provide only limiting amounts of free I2 since the dissociation constant for I3-in (CH3)2SO is 10-6.2 (12) .
16 Goitrogenic compounds are listed in Table 1 . Of these, seven react readily with I2; isonicotinic acid hydrazide and 4-aminosalicylic acid react slowly; and seven of the goitrogens (tetramethylthiourea, 5,5-diethylthiobarbituric acid, 4,4'-methylenedianiline, 1,1 ,S-tricyano-2-amino-1-propene, resorcinol, sulfadiazine, and sulfanilamide) do not reduce I2 at a significantly measurable rate (Table 2) . DISCUSSION The study of the reaction of the goitrogens with N-iodosuccinimide in (CH3)2S0 has shown that the goitrogens tested react in some significant manner that differs from their nongoitrogenic analogs or derivatives. It is not known whether N-iodosuccinimide alone reacts exclusively with the compound or whether some of the newly formed I2 is also involved. The relative rates of N-iodosuccinimide attack, of the formation of 12 from the I -released in the first phase of the reaction, or of 12 with the compound under the conditions of the N-iodosuccinimide reaction (i.e., no free I-present) are not known. The I2, however, if involved, would be reduced back to I -(two I -per I2) and would again be converted to I2 by the excess N-iodosuccinimide.
In the absence of detailed knowledge of the chemistry of the reaction of N-iodosuccinimide with the goitrogens, and assuming that N-iodosuccinimide itself is the reactive agent, two possibilities for the primary attack are evident: either the goitrogen attacks the iodine atom to form an iodinated goitrogen compound (i.e., RSI), or the goitrogen attacks the nitrogen atom to form an imide of some kind (e.g., sulfeniwant of evidence and for the sake of simplicity, we have chosen the first possibility for discussion.
The oxidation products of the goitrogens resulting from the action of N-iodosuccinimide remain to be investigated. For 3-mercapto-1,2,4-triazole and the three thiouracil compounds tested, all aromatic, one may surmise that the corresponding disulfide is the major product. For nonaromatic thiourea, which yields 2. The use of (CH3)2SO (0.1 M H20) as a solvent in which to perform these investigations may lead to a new insight into the chemistry of the oxidation of sulfur compounds by iodine compounds. Miller, Roblin, and Astwood (13) found that the reaction of I2 with some of the sulfur-containing goitrogens led to the disappearance of 6-8 equivalents (3-4 mol) of I2 per mol of goitrogen, indicating that these compounds were oxidized to the sulfonic acid stage. In (CH3)2SO, under the conditions given in this work, the sulfur compounds are oxidized to a significantly lower state of oxidation. It has been repeatedly observed that upon the addition of water to the (CH3)2SO solvent the iodine coloration disappears, indicating a further oxidation of the sulfur compound.
The reasoning applied to the sulfur-containing compounds is extended to the nitrogen-and oxygen-containing goitrogens. In these cases, a labile RNI or ROI intermediate is postulated.
Most of the nitrogen-containing goitrogens yield about 1 mol of I2 per NH2 group. The sulfonamide derivatives do not yield iodine or iodide as products, and cannot, therefore, be compared with the others.
4-Aminosalicylic acid reacts as if it were a resorcinol derivative, which it is chemically, and should be considered as an example of a resorcinol type of goitrogen. Their biological activities, as determined in the 15-min rat assay (14) , are similar.
Although there is no linear relationship between the magnitude of the ieaction of a compound with N-iodosuccinimide and its goitrogenic activity, a good correlation exists. In general, the most active goitrogens react most strongly with N-iodosuccinimide. Cysteine and 6-amino-2-thiouracil are the notable exceptions. These compounds react strongly with both N-iodosuccinimide and I2 and have no goitrogenic activity. This result is not unexpected, since the chemistry of a compound is not the only factor involved in determining the biological potency of a compound. Absorption, permeability, hydrophobicity, its rate of metabolism, etc. must be considered.
6-Amino-2-thiouracil, which shows no goitrogenic activity mide), eliminating the 1-, which is a good leaving group. For Proc. Nat. Acad. Sci. USA 70 (1973) when administered orally (3) or intraperitoneally (14) , does inhibit a glycerol-extracted crude preparation of thyroid peroxidase when tested by the guaiacol assay (unpublished observations). The general reactivity of N-iodosuccinimide indicates that the S-containing goitrogen compounds react more readily than the N-containing ones, and the 0-containing compounds react least readily. This sequence is in line with their overall goitrogenic potencies and is inversely related to the electronegativities of S (2.5), N (3.0), and O (3.5).
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